Evidence map›Paper›PMID 35564733›Full record

ArticleInternational journal of environmental research and public health2022

Self-Reported Medication Use among Pregnant and Postpartum Women during the Third Wave of the COVID-19 Pandemic: A European Multinational Cross-Sectional Study.

Eva Gerbier, Guillaume Favre, Fatima Tauqeer, Ursula Winterfeld, Milos Stojanov, Alison Oliver, Anneke Passier, Hedvig Nordeng, Léo Pomar, David Baud and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Pharmacotherapy during Pregnancy, Childbirth, and Lactation.International journal of environmental research and public health · 2022
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Eva GerbierMaterno-Fetal and Obstetrics Research Unit, Department "Woman-Mother-Child", Lausanne University Hospital, 1011 Lausanne, Switzerland.
Guillaume FavreMaterno-Fetal and Obstetrics Research Unit, Department "Woman-Mother-Child", Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0001-6181-3126
Fatima TauqeerPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, N-0315 Oslo, Norway.
Ursula WinterfeldSwiss Teratogen Information Service and Clinical Pharmacology Service, CHUV, 1066 Lausanne, Switzerland.ORCID 0000-0002-9926-7164
Milos StojanovMaterno-Fetal and Obstetrics Research Unit, Department "Woman-Mother-Child", Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0002-5166-5841
Alison OliverUK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust and the UK Health Security Agency, Newcastle upon Tyne NE3 3HD, UK.
Anneke PassierTeratology Information Service, Pharmacovigilance Centre Lareb, 's Hertogenbosch, 5237 MH Hertogenbosch, The Netherlands.ORCID 0000-0001-5594-6360
Hedvig NordengPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, N-0315 Oslo, Norway.ORCID 0000-0001-6361-2918
Léo PomarMaterno-Fetal and Obstetrics Research Unit, Department "Woman-Mother-Child", Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0002-3021-8129
David BaudMaterno-Fetal and Obstetrics Research Unit, Department "Woman-Mother-Child", Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0001-9914-6496
Alice PanchaudMaterno-Fetal and Obstetrics Research Unit, Department "Woman-Mother-Child", Lausanne University Hospital, 1011 Lausanne, Switzerland.ORCID 0000-0001-6086-2401
Carla Meyer-MassettiInstitute of Primary Health Care (BIHAM), University of Bern, CH-3012 Bern, Switzerland.ORCID 0000-0002-3523-5729
Michael CeulemansTeratology Information Service, Pharmacovigilance Centre Lareb, 's Hertogenbosch, 5237 MH Hertogenbosch, The Netherlands.ORCID 0000-0002-4130-5869
University of Lausanne · CHNetherlands Pharmacovigilance Centre Lareb · NLUniversity of Bern · CHHES-SO University of Applied Sciences and Arts Western Switzerland · CHNewcastle upon Tyne Hospitals NHS Foundation Trust · GBNorwegian Institute of Public Health · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Information on medication utilization among pregnant and postpartum women during the pandemic is lacking. We described the prevalence and patterns of self-reported medication use among pregnant and postpartum women during the third wave of the pandemic (June-August 2021). An online questionnaire was distributed in five European countries between June-August 2021. Pregnant women or women who had delivered in the three preceding months, and ≥18 years old, could participate. The prevalence of overall medication use, self-medication, and changes in chronic medication use were determined. A total of 2158 women out of 5210 participants (41.4%) used at least one medication. Analgesics (paracetamol), systemic antihistamines (cetirizine), and drugs for gastric disorders (omeprazole) were the three most used classes. Anti-infectives were less prevalent than during pre-pandemic times. Antidepressants and anxiety related medication use remained similar, despite a higher prevalence of these symptoms. Self-medication was reported in 19.4% of women, and 4.1% of chronic medication users reported that they changed a chronic medication on personal initiative due to the pandemic. In conclusion, medication use patterns in our cohort were mostly similar to those of the first COVID-19 wave and the pre-pandemic period. More studies are needed to explore factors associated with self-medication and changes in chronic medication use due to the pandemic in this perinatal population.

Indexed as

COVID-19COVID-19 Drug TreatmentAdolescentAnxietyCross-Sectional StudiesFemaleHumansPandemicsParturitionPostpartum PeriodPregnancyPregnant PeopleSelf Reportchronic diseaseCOVID-19drug utilizationEuropemedication usepandemicpharmacoepidemiologypostpartumpregnancyself-medication

Identifiers

PMID35564733
PMCPMC9100043
OpenAlexW4224982875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.